Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options.

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Medicine

Background:

• Carbapenem-resistant Acinetobacter baumannii (CRAB) is a significant pathogen in hospitalized patients, causing both colonization and infection.
• Differentiating CRAB colonization from infection is clinically challenging but essential for guiding antimicrobial therapy.

Purpose of the Study:

• To provide guidance on differentiating CRAB colonization from infection.
• To review current treatment strategies for CRAB infections.
• To emphasize the importance of specialist consultation in managing CRAB infections.

Main Methods:

• Clinical criteria for distinguishing colonization from infection based on sample source and patient signs/symptoms.
• Review of current evidence for antimicrobial agents and combination therapies against CRAB.
• Discussion of treatment considerations for CRAB in the presence of indwelling medical devices.

Main Results:

• CRAB in non-sterile sites likely represents colonization unless clear infection signs are present; treatment is reserved for confirmed infections.
• In sterile sites, CRAB presence with indwelling devices requires device management and potential treatment if infection signs are evident.
• No single agent is superior; ampicillin-sulbactam shows good evidence for initial use, and combination therapy is generally preferred.

Conclusions:

• Accurate differentiation between CRAB colonization and infection is critical for appropriate patient management.
• Combination therapy, often including high-dose ampicillin-sulbactam, is the recommended approach for CRAB infections.
• Management of CRAB infections necessitates a multidisciplinary approach, involving infectious disease specialists.